Air–liquid interface
Expose cultured respiratory tissue under dynamic airflow.
[ Microphysiological Systems ]
MPS-CORE
Precise aerosol delivery for inhaled-drug research.
Deliver aerosols to lung-on-chip tissues at an air–liquid interface. Dynamic airflow supports studies of deposition, absorption and clearance for inhalable treatments including liposomes and nanoparticles.
Request product information[ TECHNICAL SPECIFICATIONS ]
Built for your next study.
Product specifications · September 2026
Download brochure- Chip capacity
- 6 chips
- Particle size
- <5 µm
- Exposure volume
- ≥200 µL
- Flow rate
- 20 mL/min
- Exposure duration
- 5–10 min
- Patent
- US11732230B2
[ IN YOUR WORKFLOW ]
Connect the product to your experiment.
Low nebulization volume
Plan aerosol exposure from a minimum volume of 200 µL.
Single-use components
Incorporate disposable components into the exposure workflow.
[ RELATED APPLICATION ]
Inhalation & Lung
Start with the respiratory model and exposure question. Plan the culture interface, controls and measurements needed to assess tissue response.
Explore the study process
[ NEXT STEP ]
Advance Your Next Drug Program with Human-Relevant Evidence.
Tell us what you’re working on. We’ll help you explore the right model, platform or collaboration.
Let’s Talk